August 4, 2023
ADAI In the News: A Round-Up of Stories on Xylazine, Fentanyl, Meth Overdose, “Health Hubs,” and More!
ADAI faculty and staff have been featured in a lot of news articles and other media lately. Here’s a round-up of some of the pieces and podcasts. (Want to be the first to know when ADAI folks are in the media? Follow us on X/Twitter!) Xylazine or “tranq” in WA: Rising drug threat or an…
March 6, 2023
Ask an Expert: Is Mandating Treatment Necessary or Helpful?
Caleb Banta-Green, PhD, MPH, MSWDirector, UW Center for Community-Engaged Epidemiology, Education, and Research (CEDEER) Substance use-related health services are a well-researched area. Many people, however, have outdated understandings of substance use and “substance use disorder” (addiction) and also don’t know much about what truly motivates someone to seek services to reduce the harms associated with…
February 22, 2023
New ADAI Report & Virtual Tour: Overview and Perspectives of Syringe Services Programs in WA State
New ADAI Report This new report, Overview and Perspectives of Syringe Services Programs in Washington State, written by Susan Kingston of the ADAI Center for Community-Engaged Drug Education, Epidemiology and Research (CEDEER), describes how Washington State syringe services programs (SSPs) operate, the services they provide, the challenges they face, and their untapped potential. Citation: Kingston…
November 23, 2022
New from ADAI: Provider Perspectives on Medication Treatment for OUD in Adolescents
Despite recent surges in adolescent opioid use disorder (OUD), teens are less likely to enter treatment compared to adults, and are rarely in treatment settings that offer evidence-based medication treatment (methadone, buprenorphine, and naltrexone). Buprenorphine is the only medication approved for people under 18 (aged 16 and older) and methadone requires written parental consent for…
November 1, 2022
ADAI’s Bia Carlini, PhD Interviewed on Q13 About High-THC Cannabis Products
Acting Associate Professor Beatriz Carlini, PhD, director of ADAI’s Cannabis Education & Research Program (CERP), was recently interviewed for Q13 FOX about the health risks of high-THC cannabis products. Dr. Carlini talks in the video about how cannabis legalization brought new jobs and less criminalization of individuals, both good things, but that the market has…
October 5, 2022
ADAI in the News: Dr. Beatriz Carlini’s Work on High-THC Cannabis Profiled in the Seattle Times
Seattle Times reporter Hannah Furfaro attended our recent ADAI Symposium on High-THC Cannabis in Legal Regulated Markets, then spoke to the Director of ADAI’s Cannabis Education & Research Project (CERP), Beatriz Carlini, PhD, MPH, as well as several other presenters at the symposium, for this article in the Seattle Times: Researchers warn of mental health…
August 17, 2022
ADAI Virtual Training: Seeing & Interacting with Trauma – Sept 14 & 21
ADAI is hosting a 2-day training this September about trauma. REGISTER HERE. The two sessions build on each other and will provide attendees with the opportunity to: Understand how common trauma is and how to recognize it. Learn how our own experience and past trauma influence interactions with clients. Learn skills to interact effectively with…
July 22, 2022
New from ADAI: Most US Adults Who Use Cannabis Also Use Other Substances
This new article, coauthored by ADAI Research Scientists Beatriz Carlini, PhD, MPH and Gillian Schauer, PhD, MPH, reports on one of the first studies to explore the prevalence of adults in the U.S. who use cannabis while abstaining from other substances. Using data from adults aged 18 or older who responded to the 2017 or…
June 17, 2022
ADAI in the News: High THC Concentration Products (Bia Carlini) and Safer Smoking Kits (Caleb Banta-Green)
High THC Concentration Products are a “Time Bomb” ADAI Research Scientist Beatriz Carlini, PhD, MPH was interviewed for an article in The Times (UK) about high THC concentration products and how it’s a “time bomb” in terms of its potential effects on the mental health of people who use it. “We are not paying attention…
May 2, 2022
ADAI in the News: High-Potency Cannabis a Concern in WA and CO
ADAI cannabis expert Beatriz Carlini, PhD, MPH was interviewed for a national NBC News article exploring the impact of high-THC concentration products in states that have legalized cannabis for retail sale, like Washington and Colorado. Dr. Carlini, who was part of a team of UW and WSU researchers who put together a consensus statement and…
« Previous Page Next Page »
